Daily Innovation News

August 13^th 2024

💻 Technology

🇨🇳 Chinese researchers develop breakthrough low-power 2D chips to boost smartphone battery life

Scientists in China have created a new type of two-dimensional, low-power computer chip using a thin layer of aluminum oxide. This innovative material enhances energy efficiency and reduces power consumption, potentially extending smartphone battery life. The new chips, which feature superior dielectric properties and smooth interfaces, are a major step forward in advancing next-generation 5G, AI, and IoT technologies, supporting the transition of 2D semiconductors from research to industrial use. This research was published in Nature.

🚘 Transport

🇬🇧 UK to launch world’s first hydrogen-to-synthetic jet fuel plant in London

OXCCU is set to open the world’s first synthetic aviation fuel (SAF) demonstrator plant at London’s Oxford Airport, using an innovative single-step process to convert hydrogen and captured carbon dioxide into jet fuel. This breakthrough could significantly reduce the cost of SAF, making it a more viable alternative for decarbonizing the aviation industry. The plant, producing one kilogram of SAF daily, is a key step toward scaling up production to meet future demand for sustainable aviation fuels.

🤖 Artificial Intelligence

🇬🇧 🇩🇪 UK and German study finds AI language models pose no existential threat to humanity

Researchers have found that large language models, like ChatGPT, do not develop independent reasoning or new skills, dispelling fears of them posing an existential threat. The study shows that these models are fully controllable and lack emergent abilities, meaning they can only perform tasks as explicitly instructed by humans. This insight suggests that concerns over AI developing hazardous abilities are unfounded, though the potential for misuse still requires attention.

🌎 Environment

🇨🇦 Canada opens world's first carbon removal facility to capture 30,000 tons of CO2 in a decade

Deep Sky has announced the construction of the world’s first carbon removal innovation and commercialization center in Alberta, Canada. The facility aims to capture 3,000 tons of CO2 annually, totaling 30,000 tons over ten years, using multiple cutting-edge Direct Air Capture (DAC) technologies. This project, set to begin operation by the end of the year, represents a significant step in global efforts to scale carbon removal and achieve net-zero emissions targets.

🇺🇸 US engineers develop a reactor that converts wastewater into green ammonia and clean water

Rice University researchers have created a revolutionary reactor that transforms nitrate-contaminated wastewater into green ammonia and purified water, offering a sustainable alternative to the energy-intensive Haber-Bosch process. This innovative system uses electrochemical synthesis at room temperature, enhancing efficiency and reducing the carbon footprint of ammonia production. The breakthrough, published in Nature Catalysis, has significant implications for both water purification and sustainable agriculture, potentially aiding in global decarbonization efforts.

💊 Healthcare

🇺🇸 🇦🇺 🇨🇳 Researchers develop glucose-responsive insulin that could reduce injections to once a week

Scientists from the US, Australia, and China have created a groundbreaking glucose-responsive insulin that adjusts to blood sugar levels in real-time, potentially reducing injection frequency for type 1 diabetes patients to just once a week. This "smart insulin" activates only when needed, preventing both hyperglycemia and hypoglycemia, and closely mimics the body's natural insulin response. The innovation could greatly ease the burden of diabetes management and improve patient outcomes.

🇺🇸 Scientists develop single-shot therapy that reduces HIV 10,000-fold in monkeys

Researchers have created a novel treatment called TIPs (therapeutic interfering particles) that dramatically reduces HIV levels in monkeys with just one injection. This engineered virus outcompetes HIV by using the same cellular machinery, reducing the virus's presence in the body up to 10,000-fold and potentially offering a long-lasting alternative to daily antiretroviral drugs. The innovation, published in Science, could be especially beneficial for people in regions with limited access to current HIV treatments. Human trials are planned to test its safety and efficacy.

That’s all for today, please reply to this email if you have any comments or feedback, we’d love to hear from you about what we can do better!

Have you enjoyed this email? Make sure to share it with your friends and colleagues.

Thanks for reading!